TGA Approval

DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial (455605)

ARTG ID

455605

ARTG Name

DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial

Sponsor

Janssen-Cilag Pty Ltd

ARTG Date

March 28, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

JANSSEN-CILAG PTY LTD

Ingredient Name

daratumumab

Empowering clinical research with data-driven insights and AI-powered tools.

DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial (455605) - TGA 批准文号 | MedPath